Investigating how the dengue vaccine works in people with prior dengue infection
Immunogenicity of the dengue vaccine CYD-TDV in a dengue virus serotype 1 immune population
This study is looking at how the dengue vaccine works better for people who have had dengue before, and it aims to find out why that is, so we can make the vaccine even more effective for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10892299 on NIH RePORTER |
What this research studies
This research focuses on understanding the immune response generated by the dengue vaccine CYD-TDV in individuals who have previously been infected with the dengue virus. The study aims to explore why the vaccine is more effective in these individuals compared to those without prior infection. By examining the role of immune cells and antibodies, researchers hope to uncover mechanisms that enhance the vaccine's effectiveness. This could lead to improved vaccination strategies for dengue prevention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 9-16 years who have a confirmed history of dengue virus infection.
Not a fit: Patients who have never been infected with the dengue virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective dengue vaccination strategies, potentially reducing the incidence of dengue fever.
How similar studies have performed: Previous research has shown that understanding immune responses to vaccines can lead to significant advancements in vaccine efficacy, suggesting potential for success in this area.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Messer, William — Oregon Health & Science University
- Study coordinator: Messer, William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.